Eastern Bankshares Inc(EBC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EBC Eastern Bankshares Inc

Post-Market Trading 11-15 17:05:07 EST

18.45

-0.11

-0.59%

盘后18.45

+0.000.00%

16:10 EST

High18.73	Low17.77	Vol608.18K
Open17.77	D1 Closing18.56	Amplitude5.17%
Mkt Cap3.96B	Tradable Cap3.63B	Total Shares214.66M
T/O11.21M	T/O Rate0.31%	Tradable Shares197.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"EBC","market":"US","secType":"STK","nameCN":"Eastern Bankshares Inc","latestPrice":18.45,"timestamp":1731704400000,"preClose":18.56,"halted":0,"volume":608182,"hourTrading":{"tag":"盘后","latestPrice":18.45,"preClose":18.45,"latestTime":"16:10 EST","volume":32370,"amount":597226.5,"timestamp":1731705016965},"delay":0,"floatShares":197000000,"shares":214663419,"eps":2.719656,"marketStatus":"Post-Market Trading","change":-0.11,"latestTime":"11-15 17:05:07 EST","open":17.77,"high":18.73,"low":17.77,"amount":11208236.09758,"amplitude":0.051724,"askPrice":18.81,"askSize":90,"bidPrice":17.72,"bidSize":1,"shortable":3,"etf":0,"ttmEps":2.719656,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1731718800000},"marketStatusCode":4,"adr":0,"listingDate":1602734400000,"exchange":"NASDAQ","adjPreClose":18.56,"dividendRate":0.023848,"postHourTrading":{"tag":"盘后","latestPrice":18.45,"preClose":18.45,"latestTime":"16:10 EST","volume":32370,"amount":597226.5,"timestamp":1731705016965},"volumeRatio":0.656772,"impliedVol":0.4173,"impliedVolPercentile":0.6944},"requestUrl":"/m/hq/s/EBC/wiki","defaultTab":"wiki","newsList":[{"id":"2483437195","title":"Fortinet Expands Global Presence with New Company-Owned Innovation Hub in Atlanta","url":"https://stock-news.laohu8.com/highlight/detail?id=2483437195","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483437195?lang=en_us&edition=fundamental","pubTime":"2024-11-15 22:00","pubTimestamp":1731679200,"startTime":"0","endTime":"0","summary":"Newly acquired 10-story building will be transformed into newest Innovation Hub from Fortinet, including FortiCloud Point of Presence, Executive Briefing Center, Training Facility, and Support Center ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/15/2982036/0/en/Fortinet-Expands-Global-Presence-with-New-Company-Owned-Innovation-Hub-in-Atlanta.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","EBC","BK4585","IE0031619046.USD","BK4560","LU2023250504.SGD","LU0079474960.USD","FTNT","BK4131","BK4588","BK4211","HUBG","IE00B7SZL793.SGD","BK4532","LU2106854487.HKD","IE00B66KJ199.SGD","LU2023250843.SGD","IE0008368304.USD","LU2286300806.USD","LU1917777945.USD","IE00B19Z4B17.USD","LU1974910355.USD","LU0348723411.USD"],"gpt_icon":1},{"id":"2480865467","title":"Lilly to Present Results from Phase 3 EMBER-3 Study of Imlunestrant, an Oral SERD, and Additional Results from Its Breast Cancer Portfolio at the San Antonio Breast Cancer Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2480865467","media":"PR Newswire","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480865467?lang=en_us&edition=fundamental","pubTime":"2024-11-02 05:30","pubTimestamp":1730496600,"startTime":"0","endTime":"0","summary":"INDIANAPOLIS, Nov. 1, 2024 /PRNewswire/ --Eli Lilly and Company  today announced that data from the Phase 3 trial  for imlunestrant, an oral selective estrogen receptor degrader , will be reported for the first time in a late-breaking oral presentation at the San Antonio Breast Cancer Symposium  taking place December 10-13 in San Antonio, TX. EMBER-3 is a study in estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative  advanced breast cancer. The trial is evaluating imlunestrant alone or in combination with Verzenio , in patients who were pretreated with endocrine therapy, with or without a CDK4/6 inhibitor.Presentation Title: Patient and health care provider perspectives on oral versus intramuscular endocrine therapy for locally advanced or metastatic breast cancerPresentation Number:P4-03-11Presentation Date & Time: Thursday, Dec.12, 2024, 5:30-7 p.m. CSTLocation: Halls 2-3Presenter:Rebecca Speck","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/lVAuq1Sjy2.E_X33eK_R8A--~B/aD0yMTk7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f3aaa8410f59c3eccd5d187ecffbd6ee","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/lVAuq1Sjy2.E_X33eK_R8A--~B/aD0yMTk7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f3aaa8410f59c3eccd5d187ecffbd6ee"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/lilly-present-results-phase-3-213000630.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lilly-present-results-phase-3-213000630.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1057294990.SGD","HR","BK4581","LU0672654240.SGD","LU0198837287.USD","LU0058720904.USD","LU1061106388.HKD","BK4590","LU0061475181.USD","LU0689472784.USD","LU0820561818.USD","LU0094547139.USD","BK4144","LU0882574055.USD","LU0256863902.USD","BK4203","LU0109391861.USD","LU1878469433.USD","IE00BJJMRZ35.SGD","AST","LU0106261372.USD","IE00B2B36J28.USD","BK4211","BK4533","LU0079474960.USD","IE00BFTCPJ56.SGD","ALT","LU0708995401.HKD","IE00BJT1NW94.SGD","LLY","EBC","LU0320765059.SGD","LU0006306889.USD","BK4534","LU1069344957.HKD","LU0256863811.USD","LU0122379950.USD","LU0096364046.USD","LU1023059063.AUD","IE0002141913.USD","IE00B4R5TH58.HKD","LU0354030438.USD","LU0823416689.USD","BK4561","IE0004445239.USD","ET","BK4007","IE0009355771.USD","LU0471298694.HKD","BK4516"],"gpt_icon":1},{"id":"2479031066","title":"Eastern Bank Names Kimberly Dee Executive Vice President, Consumer Banking Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2479031066","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479031066?lang=en_us&edition=fundamental","pubTime":"2024-10-31 23:00","pubTimestamp":1730386800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241031:nTUA3TTB3D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EBC","BK4211"],"gpt_icon":0},{"id":"2479323920","title":"Eastern Bank Names Kimberly Dee Executive Vice President, Consumer Banking Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2479323920","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479323920?lang=en_us&edition=fundamental","pubTime":"2024-10-31 23:00","pubTimestamp":1730386800,"startTime":"0","endTime":"0","summary":"BOSTON, October 31, 2024----Eastern Bank, Greater Boston’s leading local bank, is pleased to announce that Kimberly Dee, a highly accomplished retail, customer transformation and business banking executive, has been named Executive Vice President, Consumer Banking Director. She will also serve on the Bank’s Management Committee, comprised of Eastern’s most senior executives. Dee most recently served as Executive Vice President and Head of the Retail Branch Network of Citizens Financial Group, where she was a member of its Executive Leadership Group.\"Central to Eastern Bank’s mission is an enduring commitment to helping customers throughout all of their life journeys and to supporting our local communities, and I’m excited to join the team and help advance this focus,\" said Dee, newly named Executive Vice President, Consumer Banking Director. \"I am grateful to build upon Barbara’s incredible legacy, and look forward to helping to deliver an unparalleled customer exper","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/h17_BIXIlUSDQSCE.PR80A--~B/aD0yNjE7dz0xMTI5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/bfd817289d298fd447eb0d0b242d78eb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/h17_BIXIlUSDQSCE.PR80A--~B/aD0yNjE7dz0xMTI5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/bfd817289d298fd447eb0d0b242d78eb"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eastern-bank-names-kimberly-dee-150000934.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EML","BK4211","EBC","BK4161"],"gpt_icon":0},{"id":"2478210470","title":"Eastern Bankshares (EBC) Gets a Hold from Janney Montgomery","url":"https://stock-news.laohu8.com/highlight/detail?id=2478210470","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478210470?lang=en_us&edition=fundamental","pubTime":"2024-10-28 20:06","pubTimestamp":1730117192,"startTime":"0","endTime":"0","summary":"In a report released today, Jake Civiello from Janney Montgomery reiterated a Hold rating on Eastern Bankshares (EBC – Research Report), with a pri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/eastern-bankshares-ebc-gets-a-hold-from-janney-montgomery?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/eastern-bankshares-ebc-gets-a-hold-from-janney-montgomery?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EBC","BK4211"],"gpt_icon":0},{"id":"2478161120","title":"Eastern Bankshares Inc reports results for the quarter ended in September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2478161120","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478161120?lang=en_us&edition=fundamental","pubTime":"2024-10-27 23:52","pubTimestamp":1730044347,"startTime":"0","endTime":"0","summary":"* Eastern Bankshares Inc    reported quarterly adjusted earnings of 25 cents per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of 32 ce","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Eastern Bankshares Inc reports results for the quarter ended in September 30 - Earnings Summary","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBC"],"gpt_icon":0},{"id":"2478920248","title":"Eastern Bankshares Third Quarter 2024 Earnings: Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2478920248","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478920248?lang=en_us&edition=fundamental","pubTime":"2024-10-26 22:24","pubTimestamp":1729952654,"startTime":"0","endTime":"0","summary":"NasdaqGS:EBC Earnings and Revenue Growth October 26th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 8.7%. Earnings per share  was also behind analyst expectations.Looking ahead, revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Banks industry in the US.The company's shares are down 7.9% from a week ago.You should learn about the   2 warning signs  we've spotted with Eastern Bankshares.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eastern-bankshares-third-quarter-2024-142414094.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EML","EBC"],"gpt_icon":0},{"id":"2478985946","title":"Eastern Bankshares Inc (EBC) Q3 2024 Earnings Call Highlights: Navigating Merger Impacts and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2478985946","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478985946?lang=en_us&edition=fundamental","pubTime":"2024-10-26 15:06","pubTimestamp":1729926400,"startTime":"0","endTime":"0","summary":"GAAP Net Loss: $6 million in the third quarter due to non-recurring merger items.Operating Net Income: $49.7 million or 25 cents per share.Net Interest Margin: Increased 33 basis points to 2.97%.Wealth Revenues: More than doubled to $14.9 million in the third quarter.Tangible Book Value Per Share: Ended the quarter at $12.17.Dividend Increase: 9% increase to 12 cents per share.Allowance for Loan Losses: Expanded to 1.43% of total loans.Non-Performing Loans: Increased to $125 million, driven by Cambridge PCD loans.Loan Accretion Income: Expected to be approximately $12 million to $14 million each quarter for the next year.Operating Non-Interest Expense: $130.9 million, with merger-related costs reflected.Assets Under Management: Over $8 billion, making it the largest bank-owned investment advisor in Massachusetts.Repurchased Shares: 836,399 shares at an average price of $15.8, totaling $12.6 million.GuruFocus has detected 5 Warning Signs with EBC.Eastern Bankshares Inc  successfully com","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/1l5ZiDZtgLvePpA8kPv4tQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/d89feb41e6d7dc86b26adfba9f289546","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/1l5ZiDZtgLvePpA8kPv4tQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/d89feb41e6d7dc86b26adfba9f289546"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eastern-bankshares-inc-ebc-q3-070640893.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EBC"],"gpt_icon":0},{"id":"1181122896","title":"Stock Track | Eastern Bankshares Stock Declines on Merger Integration Costs and Office Loan Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1181122896","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181122896?lang=en_us&edition=fundamental","pubTime":"2024-10-26 01:34","pubTimestamp":1729877672,"startTime":"0","endTime":"0","summary":"Eastern Bankshares Inc.  saw its stock plummet 5.32% on October 25, 2024, following the release of its third-quarter earnings results. The decline appeared to be fueled by the company's higher expenses related to its merger integration with Cambridge Trust, as well as concerns over the weakness in the office commercial real estate market.In its Q3 2024 earnings call, EBC reported that it had completed the merger with Cambridge Trust during the quarter, which expanded its operations but also led ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Eastern Bankshares Stock Declines on Merger Integration Costs and Office Loan Concerns","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["EBC"],"gpt_icon":0},{"id":"2478545379","title":"Eastern Bankshares (EBC) Q3 2024 Earnings Call Transcript","url":"https://stock-news.laohu8.com/highlight/detail?id=2478545379","media":"Motley Fool Transcribing","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478545379?lang=en_us&edition=fundamental","pubTime":"2024-10-26 01:15","pubTimestamp":1729876516,"startTime":"0","endTime":"0","summary":"EBC earnings call for the period ending September 30, 2024.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com/earnings/call-transcripts/2024/10/25/eastern-bankshares-ebc-q3-2024-earnings-call-trans/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_motley_transcript","symbols":["EBC"],"gpt_icon":0},{"id":"2478936438","title":"Eastern Bankshares Inc : Piper Sandler Cuts Target Price to $19 From $20","url":"https://stock-news.laohu8.com/highlight/detail?id=2478936438","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478936438?lang=en_us&edition=fundamental","pubTime":"2024-10-25 22:16","pubTimestamp":1729865794,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241025:nFWN3M11VS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EBC","BK4211"],"gpt_icon":0},{"id":"2478693584","title":"Eastern Bankshares Q3 2024 Adj. EPS $0.25 Misses $0.33 Estimate, Sales $203.383M Beat $182.279M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2478693584","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478693584?lang=en_us&edition=fundamental","pubTime":"2024-10-25 04:20","pubTimestamp":1729801247,"startTime":"0","endTime":"0","summary":"Eastern Bankshares (NASDAQ:EBC) reported quarterly earnings of $0.25 per share which missed the analyst consensus estimate of $0.33 by 24.24 percent.  The company reported quarterly sales of $203.383 million which beat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/10/41530489/eastern-bankshares-q3-2024-adj-eps-0-25-misses-0-33-estimate-sales-203-383m-beat-182-279m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EML","EBC"],"gpt_icon":0},{"id":"2478169512","title":"Eastern Bankshares, Inc. Reports Third Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2478169512","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478169512?lang=en_us&edition=fundamental","pubTime":"2024-10-25 04:18","pubTimestamp":1729801080,"startTime":"0","endTime":"0","summary":"~ Company Announces a 9% Increase to Quarterly Dividend ~BOSTON, October 24, 2024----Eastern Bankshares, Inc.  , the holding company of Eastern Bank, today announced its 2024 third quarter financial results.Net loss of $6.2 million included the initial provision on non-purchased credit deteriorated  loans of $40.9 million and merger-related charges of $30.5 million. Operating net income of $49.7 million, or 0.25 per diluted share.Merger EPS accretion and cost saves on track to exceed original estimates.Net interest margin on a fully tax equivalent  basis of 2.97%, an increase of 0.33%, including net discount accretion from the Cambridge merger of 0.18%.Trust and investment advisory fees increased $8.2 million, or 122%, from the prior quarter to $14.9 million, due primarily to increased assets under management  as a result of the merger.Book value per share and tangible book value per share ended the quarter at $17.09 and $12.17, respectively.Non-performing loans  increased by $84.7 mil","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/WsLFjVQaNf_i9UHDtG8oNw--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f954a39958050750fcc4991a6b5a1a0f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/WsLFjVQaNf_i9UHDtG8oNw--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f954a39958050750fcc4991a6b5a1a0f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eastern-bankshares-inc-reports-third-201800136.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EML","EBC","BK4211","BK4161","WRD"],"gpt_icon":0},{"id":"2477526836","title":"Novartis ribociclib (Kisqali®) recognized as Category 1 preferred breast cancer adjuvant treatment by NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)","url":"https://stock-news.laohu8.com/highlight/detail?id=2477526836","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477526836?lang=en_us&edition=fundamental","pubTime":"2024-10-24 13:15","pubTimestamp":1729746900,"startTime":"0","endTime":"0","summary":"Ribociclib (Kisqali) plus aromatase inhibitor (AI) recommended for HR+/HER2- early breast cancer (EBC) node-positive and high-risk node-negative patients, as studied in the NATALEE trial and indicated","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/24/2968342/0/en/Novartis-ribociclib-Kisqali-recognized-as-Category-1-preferred-breast-cancer-adjuvant-treatment-by-NCCN-Clinical-Practice-Guidelines-in-Oncology-NCCN-Guidelines.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4166","OS","BK4561","ET","BK4588","BK4590","BK4581","EBC","BK4211","FUL","MBC","ML","BK4109","BK4144","BK4585","BK4097","BK4086"],"gpt_icon":0},{"id":"2477347143","title":"Eastern Bankshares Inc    expected to post earnings of 33 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2477347143","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477347143?lang=en_us&edition=fundamental","pubTime":"2024-10-23 11:54","pubTimestamp":1729655694,"startTime":"0","endTime":"0","summary":"* Eastern Bankshares Inc     is expected to show a rise in quarterly revenue when it reports  results on October 24 for the period ending September 30 2024   * The Boston Massachusetts-based  company ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Eastern Bankshares Inc    expected to post earnings of 33 cents a share - Earnings Preview","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBC"],"gpt_icon":0},{"id":"2477681350","title":"Novartis Gets CHMP Recommendation for Kisqali in Broader Population","url":"https://stock-news.laohu8.com/highlight/detail?id=2477681350","media":"Zacks","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477681350?lang=en_us&edition=fundamental","pubTime":"2024-10-22 01:51","pubTimestamp":1729533060,"startTime":"0","endTime":"0","summary":"Novartis NVS announced that the Committee for Medicinal Products for Human Use  of the European Medicines Agency  recommended granting approval to the breast cancer drug Kisqali  for a broader patient population.The CHMP adopted a positive opinion for the marketing authorization for Kisqali for the adjuvant treatment of adults with hormone receptor-positive/human epidermal growth factor receptor 2-negative  early breast cancer , at high risk of disease recurrence, including those with node-negative disease.Year to date, shares of Novartis have risen 16.1% compared with the industry’s growth of 20.6%.Kisqali is a selective cyclin-dependent kinase inhibitor, a class of drugs that help slow cancer progression by inhibiting two proteins — cyclin-dependent kinase 4 and 6 .The positive CHMP decision for a broad population of patients diagnosed with HR+/HER2- EBC at high risk of recurrence is based on robust data from the late-stage NATALEE study.Following the CHMP’s positive recommendation, ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Tw87WEC1wh0JNb8.IBuFMA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/03fca48475577988aa4e0db94f484b4e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Tw87WEC1wh0JNb8.IBuFMA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/03fca48475577988aa4e0db94f484b4e"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novartis-gets-chmp-recommendation-kisqali-175100743.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4581","EC","LU0211331839.USD","BK4211","LU1035775433.USD","BK4532","IE00B4R5TH58.HKD","GB00BDT5M118.USD","LU0109391861.USD","BK4578","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","LU0320765059.SGD","BK4533","LU0096364046.USD","BK4585","IE00BJLML261.HKD","LU0820561818.USD","LU0417517546.SGD","LU1023059063.AUD","IE0004445239.USD","BAYRY","LU0882574139.USD","LU0882574055.USD","CHMP","LU0094547139.USD","LU0122379950.USD","IE0002141913.USD","LU0471298777.SGD","IE00BFTCPJ56.SGD","ET","IE00B2B36J28.USD","NVS","LU0354030438.USD","LU0114720955.EUR","LU0061475181.USD","IE00BJJMRZ35.SGD","LU0466842654.USD","BK4561","LU0079474960.USD","LU0203202063.USD","LU0823416689.USD","IE00BK4W5L77.USD","LU0289739699.SGD","EBC","BK4516","LU0238689110.USD","LLY","LU1057294990.SGD","BK4534"],"gpt_icon":1},{"id":"2476295572","title":"European Medicines Agency's Panel Supports Approval Of Novartis' Kisqali In Patients With Early-Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2476295572","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476295572?lang=en_us&edition=fundamental","pubTime":"2024-10-19 01:37","pubTimestamp":1729273028,"startTime":"0","endTime":"0","summary":"On Friday,Novartis AG  announced that the European Medicines Agency’s  Committee for Medicinal Products for Human Use  has adopted a positive opinion for Kisqali .The CHMP recommended approval granting marketing authorization for Kisqali  for the adjuvant treatment of adults with hormone receptor-positive/human epidermal growth factor receptor 2-negative  early breast cancer , at high risk of disease recurrence, including those with node-negative disease.Also Read: Goldman Sachs Shifts Stance On Novartis, Cites Lack Of Near-Term Catalysts.The CHMP decision is based on data from the Phase 3 NATALEE trial.In the trial, Kisqali plus endocrine therapy , compared to ET alone, lowered the risk of cancer recurrence by 25.1% in patients with stage II and III HR+/HER2- EBC.The data also demonstrated a consistent, clinically meaningful invasive disease-free survival  benefit across key pre-specified subgroups.Data from the pivotal trial also showed that the safety profile of Kisqali at the 400mg","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Z6nxZ1dkWE6XVmXTuGaqJQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/c94a5df59fd910fbf3b86fb38cfa8793","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Z6nxZ1dkWE6XVmXTuGaqJQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/c94a5df59fd910fbf3b86fb38cfa8793"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/european-medicines-agencys-panel-supports-173708863.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0211331839.USD","EC","CHMP","BK4581","BK4007","IE0009355771.USD","EBC","BK4590","BK4201","IE00B2B36J28.USD","BK4578","ET","MDCO","IE00BJT1NW94.SGD","BK4144","IE00BJJMRZ35.SGD","BK4561","BK4211","BK4585","IE0002141913.USD","NVS","BK4087","BK4532","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4588"],"gpt_icon":0},{"id":"2476286865","title":"Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2476286865","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476286865?lang=en_us&edition=fundamental","pubTime":"2024-10-18 18:47","pubTimestamp":1729248420,"startTime":"0","endTime":"0","summary":"If approved, patients in Europe with stage II or III HR+/HER2- early breast cancer (EBC) at high risk of recurrence, including those with node-negative disease, will be eligible for adjuvant treatment","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/18/2965447/0/en/Novartis-receives-positive-CHMP-opinion-for-Kisqali-to-help-reduce-risk-of-recurrence-in-people-with-HR-HER2-early-breast-cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4225","BK4585","HR","ML","BK4588","BK4561","BK4166","BK4581","BK4086","FUL","BK4590","BK4097","CHMP","BK4201","EC","BK4087","BK4203","EBC","OS","MBC","BK4109","BK4211","ET","BK4144"],"gpt_icon":0},{"id":"2476170439","title":"Eastern Bankshares, Inc. (EBC) Earnings Expected to Grow: Should You Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2476170439","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476170439?lang=en_us&edition=fundamental","pubTime":"2024-10-17 22:01","pubTimestamp":1729173687,"startTime":"0","endTime":"0","summary":"The market expects Eastern Bankshares, Inc.  to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 24. On the other hand, if they miss, the stock may move lower.While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.This company is expected to post quarterly earnings of $0.33 per share in its upcoming report, which represents a year-over-year change of +3.1%.Revenues are ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ksLAzii1aL14haHFbPC1Rg--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/bdc2850a48a0f40806db817a9e24f36f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ksLAzii1aL14haHFbPC1Rg--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/bdc2850a48a0f40806db817a9e24f36f"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eastern-bankshares-inc-ebc-earnings-140127140.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EBC","INBK"],"gpt_icon":0},{"id":"2472614554","title":"Press Release: Eastern Bankshares, Inc. Announces Third Quarter 2024 Earnings Release Date, Conference Call and Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2472614554","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472614554?lang=en_us&edition=fundamental","pubTime":"2024-10-03 22:36","pubTimestamp":1727966160,"startTime":"0","endTime":"0","summary":"Eastern Bankshares, Inc.  , a Massachusetts corporation and the stock holding company for Eastern Bank, today announced the following details regarding the report of the Company's third quarter 2024 results:. Earnings Release:   Thursday, October 24, 2024 after the market close. Conference Call:    Friday, October 25, 2024 at 9:00 AM Eastern Time. Webcast:            The conference call will be simultaneously webcast.Participants may join the webcast on the Company's. replay of the webcast will be made available on demand on","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBC","EML"],"gpt_icon":0}],"profile":{"websiteUrl":"http://investor.easternbank.com","stockEarnings":[{"period":"1week","weight":0.0203},{"period":"1month","weight":0.0982},{"period":"3month","weight":0.1867},{"period":"6month","weight":0.288},{"period":"1year","weight":0.492},{"period":"ytd","weight":0.307}],"compareEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0704},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.3195},{"period":"ytd","weight":0.2483}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Eastern Bankshares, Inc. operates as the bank holding company for Eastern Bank that provides banking products and services primarily to retail, commercial, and small business customers. It operates in two segments, Banking Business and Insurance Agency Business. The company provides deposit accounts, interest checking accounts, money market accounts, savings accounts, and time certificates of deposit accounts. It also offers commercial and industrial, commercial real estate and construction, small business, residential real estate, and home equity loans; lines of credit; and other consumer loans comprising unsecured personal lines of credit, overdraft protection, automobile loans, home improvement loans, airplane loans, and other personal loans. In addition, the company provides trust, financial planning and portfolio management, automated lock box collection, cash management, and account reconciliation services; personal, business, and employee benefits insurance products. It operates branch offices in eastern Massachusetts and southern New Hampshire; and non-branch offices in eastern Massachusetts, and Providence, Rhode Island. Eastern Bankshares, Inc. was founded in 1818 and is headquartered in Boston, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.011667},{"month":2,"riseRate":0.5,"avgChangeRate":0.006685},{"month":3,"riseRate":0.5,"avgChangeRate":-0.011957},{"month":4,"riseRate":0.25,"avgChangeRate":-0.042534},{"month":5,"riseRate":0.75,"avgChangeRate":0.02211},{"month":6,"riseRate":0.5,"avgChangeRate":0.004436},{"month":7,"riseRate":0.75,"avgChangeRate":0.083338},{"month":8,"riseRate":0.5,"avgChangeRate":0.001976},{"month":9,"riseRate":0.5,"avgChangeRate":-0.015967},{"month":10,"riseRate":0.25,"avgChangeRate":-0.031612},{"month":11,"riseRate":0.8,"avgChangeRate":0.090695},{"month":12,"riseRate":0.75,"avgChangeRate":0.04274}],"exchange":"NASDAQ","name":"Eastern Bankshares Inc","nameEN":"Eastern Bankshares Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Eastern Bankshares Inc(EBC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Eastern Bankshares Inc(EBC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Eastern Bankshares Inc,EBC,Eastern Bankshares Inc股票,Eastern Bankshares Inc股票老虎,Eastern Bankshares Inc股票老虎国际,Eastern Bankshares Inc行情,Eastern Bankshares Inc股票行情,Eastern Bankshares Inc股价,Eastern Bankshares Inc股市,Eastern Bankshares Inc股票价格,Eastern Bankshares Inc股票交易,Eastern Bankshares Inc股票购买,Eastern Bankshares Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Eastern Bankshares Inc(EBC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Eastern Bankshares Inc(EBC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction